Shenzhen Salubris Pharmaceuticals Co., Ltd.

Quick facts

Marketed products

• Enarodustat 2mg
• FORSTEO · Endocrinology / Bone Metabolism
  Forsteo (teriparatide) is a recombinant human parathyroid hormone analog that stimulates bone formation by activating PTH1 receptors on osteoblasts.

Phase 3 pipeline

• Allisartan Isoproxil/Sustained-Release Indapamide · Cardiovascular
  This combination drug lowers blood pressure by blocking angiotensin II receptors (allisartan isoproxil) and inhibiting sodium reabsorption in the kidney (sustained-release indapamide).
• SAL-0951
  SAL-0951 is a small molecule inhibitor targeting a specific molecular pathway involved in disease pathogenesis.
• SAL-0951 tablets · Diabetes
  SAL-0951 tablets are a small molecule drug that targets the SGLT2 receptor.
• SAL056 (56.5μg) · Respiratory / Pulmonology
  SAL056 is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in lung tissue.
• SAL067
  SAL067 is a small-molecule inhibitor targeting a specific kinase or receptor involved in disease pathogenesis.

Phase 1 pipeline

• SAL001
• SAL0123
• SAL0133
• SAL0140
• Sequence A T-R-T-R
• Sequence B R-T-R-T

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Shenzhen Salubris Pharmaceuticals Co., Ltd. portfolio CI brief
• Shenzhen Salubris Pharmaceuticals Co., Ltd. pipeline updates RSS